These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1611504)

  • 1. Characterization of a putatively vesicular binding site for [3H]MPP+ in mouse striatal membranes.
    Del Zompo M; Piccardi MP; Ruiu S; Corsini GU; Vaccari A
    Brain Res; 1992 Feb; 571(2):354-7. PubMed ID: 1611504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential interaction of 1-methyl-4-phenylpyridinium ion with the putatively vesicular binding site of [3H]tyramine in dopaminergic and nondopaminergic brain regions.
    Vaccari A; Saba PL; Gessa GL; Del Zompo M
    J Neurochem; 1993 Feb; 60(2):758-60. PubMed ID: 8419550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier-mediated efflux of [3H]dopamine and [3H]1-methyl-4-phenylpyridine: effect of ascorbic acid.
    Debler EA; Sershen H; Hashim A; Lajtha A; Reith ME
    Synapse; 1991 Feb; 7(2):99-105. PubMed ID: 2011830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamine.
    Vaccari A; Del Zompo M; Melis F; Gessa GL; Rossetti ZL
    Br J Pharmacol; 1991 Nov; 104(3):573-4. PubMed ID: 1797320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High affinity binding sites for 1-methyl-4-phenyl-pyridinium ion (MPP+) are present in mouse brain.
    Del Zompo M; Bernardi F; Maggio R; Piccardi M; Johannessen JN; Corsini GU
    Eur J Pharmacol; 1986 Sep; 129(1-2):87-92. PubMed ID: 3490391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of monoaminergic vesicular carriers: pharmacological evidence using MPP+ as a marker.
    Ruiu S; Piccardi MP; Bocchetta A; Del Zompo M
    Life Sci; 1996; 59(20):1703-10. PubMed ID: 8890944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diethyldithiocarbamate and disulfiram inhibit MPP+ and dopamine uptake by striatal synaptosomes.
    Di Monte D; Irwin I; Kupsch A; Cooper S; DeLanney LE; Langston JW
    Eur J Pharmacol; 1989 Jul; 166(1):23-9. PubMed ID: 2553428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-affinity binding of [3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion to mouse striatal membranes: putative vesicular location.
    Del Zompo M; Piccardi MP; Ruiu S; Corsini GU; Vaccari A
    Eur J Pharmacol; 1991 Sep; 202(2):293-4. PubMed ID: 1802748
    [No Abstract]   [Full Text] [Related]  

  • 9. Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons.
    Cleren C; Naudin B; Costentin J
    Brain Res; 2003 Nov; 989(2):187-95. PubMed ID: 14556940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascorbic acid and striatal transport of [3H] 1-methyl-4-phenylpyridine (MPP+) and [3H] dopamine.
    Debler EA; Hashim A; Lajtha A; Sershen H
    Life Sci; 1988; 42(25):2553-9. PubMed ID: 3260319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes.
    Willoughby J; Cowburn RF; Hardy JA; Glover V; Sandler M
    J Neurochem; 1989 Feb; 52(2):627-31. PubMed ID: 2783454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity binding of [3H]-tyramine in the central nervous system.
    Vaccari A
    Br J Pharmacol; 1986 Sep; 89(1):15-25. PubMed ID: 3801770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of uptake of 1-methyl-4-phenylpyridinium ion and dopamine in striatal synaptosomes by tobacco smoke components.
    Carr LA; Basham JK; York BK; Rowell PP
    Eur J Pharmacol; 1992 May; 215(2-3):285-7. PubMed ID: 1396992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ascorbic acid on the synaptosomal uptake of [3H]MPP+, [3H]dopamine, and [14C]GABA.
    Sershen H; Debler EA; Lajtha A
    J Neurosci Res; 1987; 17(3):298-301. PubMed ID: 3496464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative abilities of MPTP and MPP+ to compete with [3H]dopamine for the rat and marmoset striatal dopamine uptake site.
    Barnes NM; Cheng CH; Costall B; Naylor RJ
    Biochem Pharmacol; 1990 Feb; 39(4):809-11. PubMed ID: 2306287
    [No Abstract]   [Full Text] [Related]  

  • 18. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
    Chiba K; Trevor AJ; Castagnoli N
    Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of 1-methyl-4-phenylpyridinium ion (MPP+) and ATP content in synaptosomes.
    Matsunaga M; Shirane Y; Aiuchi T; Nakamura Y; Nakaya K
    Biol Pharm Bull; 1996 Jan; 19(1):29-33. PubMed ID: 8820906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.
    Del Zompo M; Piccardi MP; Ruiu S; Quartu M; Gessa GL; Vaccari A
    Br J Pharmacol; 1993 Jun; 109(2):411-4. PubMed ID: 8102929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.